Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C10H17N3S.2ClH.H2O |
Molecular Weight | 302.264 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O.Cl.Cl.CCCN[C@H]1CCC2=C(C1)SC(N)=N2
InChI
InChIKey=APVQOOKHDZVJEX-QTPLPEIMSA-N
InChI=1S/C10H17N3S.2ClH.H2O/c1-2-5-12-7-3-4-8-9(6-7)14-10(11)13-8;;;/h7,12H,2-6H2,1H3,(H2,11,13);2*1H;1H2/t7-;;;/m0.../s1
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EMA ASSESSMENT REPORTS |
PRAMIPEXOLE ACCORD (AUTHORIZED: RESTLESS LEGS SYNDROME)
Created by
admin on Fri Dec 15 15:30:14 UTC 2023 , Edited by admin on Fri Dec 15 15:30:14 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
MIRAPEXIN (AUTHORIZED: RESTLESS LEGS SYNDROME)
Created by
admin on Fri Dec 15 15:30:14 UTC 2023 , Edited by admin on Fri Dec 15 15:30:14 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
PRAMIPEXOLE TEVA (AUTHORIZED: PARKINSON DISEASE)
Created by
admin on Fri Dec 15 15:30:14 UTC 2023 , Edited by admin on Fri Dec 15 15:30:14 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
SIFROL (AUTHORIZED: RESTLESS LEGS SYNDROME)
Created by
admin on Fri Dec 15 15:30:14 UTC 2023 , Edited by admin on Fri Dec 15 15:30:14 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
MIRAPEXIN (AUTHORIZED: PARKINSON DISEASE)
Created by
admin on Fri Dec 15 15:30:14 UTC 2023 , Edited by admin on Fri Dec 15 15:30:14 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
PRAMIPEXOLE ACCORD (AUTHORIZED: PARKINSON DISEASE)
Created by
admin on Fri Dec 15 15:30:14 UTC 2023 , Edited by admin on Fri Dec 15 15:30:14 UTC 2023
|
||
|
NCI_THESAURUS |
C66884
Created by
admin on Fri Dec 15 15:30:14 UTC 2023 , Edited by admin on Fri Dec 15 15:30:14 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
OPRYMEA (AUTHORIZED: PARKINSON DISEASE)
Created by
admin on Fri Dec 15 15:30:14 UTC 2023 , Edited by admin on Fri Dec 15 15:30:14 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
DAQUIRAN (WITHDRAWN: PARKINSON DISEASE)
Created by
admin on Fri Dec 15 15:30:14 UTC 2023 , Edited by admin on Fri Dec 15 15:30:14 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
SIFROL (AUTHORIZED: PARKINSON DISEASE)
Created by
admin on Fri Dec 15 15:30:14 UTC 2023 , Edited by admin on Fri Dec 15 15:30:14 UTC 2023
|
||
|
NCI_THESAURUS |
C38149
Created by
admin on Fri Dec 15 15:30:14 UTC 2023 , Edited by admin on Fri Dec 15 15:30:14 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID1044227
Created by
admin on Fri Dec 15 15:30:14 UTC 2023 , Edited by admin on Fri Dec 15 15:30:14 UTC 2023
|
PRIMARY | |||
|
1553859
Created by
admin on Fri Dec 15 15:30:14 UTC 2023 , Edited by admin on Fri Dec 15 15:30:14 UTC 2023
|
PRIMARY | |||
|
236747
Created by
admin on Fri Dec 15 15:30:14 UTC 2023 , Edited by admin on Fri Dec 15 15:30:14 UTC 2023
|
PRIMARY | RxNorm | ||
|
191217-81-9
Created by
admin on Fri Dec 15 15:30:14 UTC 2023 , Edited by admin on Fri Dec 15 15:30:14 UTC 2023
|
PRIMARY | |||
|
3D867NP06J
Created by
admin on Fri Dec 15 15:30:14 UTC 2023 , Edited by admin on Fri Dec 15 15:30:14 UTC 2023
|
PRIMARY | |||
|
CHEMBL301265
Created by
admin on Fri Dec 15 15:30:14 UTC 2023 , Edited by admin on Fri Dec 15 15:30:14 UTC 2023
|
PRIMARY | |||
|
51147
Created by
admin on Fri Dec 15 15:30:14 UTC 2023 , Edited by admin on Fri Dec 15 15:30:14 UTC 2023
|
PRIMARY | |||
|
51148
Created by
admin on Fri Dec 15 15:30:14 UTC 2023 , Edited by admin on Fri Dec 15 15:30:14 UTC 2023
|
PRIMARY | |||
|
DBSALT001198
Created by
admin on Fri Dec 15 15:30:14 UTC 2023 , Edited by admin on Fri Dec 15 15:30:14 UTC 2023
|
PRIMARY | |||
|
SUB25197
Created by
admin on Fri Dec 15 15:30:14 UTC 2023 , Edited by admin on Fri Dec 15 15:30:14 UTC 2023
|
PRIMARY | |||
|
C29374
Created by
admin on Fri Dec 15 15:30:14 UTC 2023 , Edited by admin on Fri Dec 15 15:30:14 UTC 2023
|
PRIMARY | |||
|
100000091470
Created by
admin on Fri Dec 15 15:30:14 UTC 2023 , Edited by admin on Fri Dec 15 15:30:14 UTC 2023
|
PRIMARY | |||
|
KK-01
Created by
admin on Fri Dec 15 15:30:14 UTC 2023 , Edited by admin on Fri Dec 15 15:30:14 UTC 2023
|
PRIMARY | |||
|
SUB12563MIG
Created by
admin on Fri Dec 15 15:30:14 UTC 2023 , Edited by admin on Fri Dec 15 15:30:14 UTC 2023
|
PRIMARY | |||
|
166589
Created by
admin on Fri Dec 15 15:30:14 UTC 2023 , Edited by admin on Fri Dec 15 15:30:14 UTC 2023
|
PRIMARY | |||
|
3D867NP06J
Created by
admin on Fri Dec 15 15:30:14 UTC 2023 , Edited by admin on Fri Dec 15 15:30:14 UTC 2023
|
PRIMARY | |||
|
m9095
Created by
admin on Fri Dec 15 15:30:14 UTC 2023 , Edited by admin on Fri Dec 15 15:30:14 UTC 2023
|
PRIMARY | Merck Index | ||
|
SUB04004MIG
Created by
admin on Fri Dec 15 15:30:14 UTC 2023 , Edited by admin on Fri Dec 15 15:30:14 UTC 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD